When you bring artificial intelligence (AI) into pharmacy workflows, its outputs can influence decisions about patient care. Clear governance and human oversight give your team a framework for evaluating those recommendations. Accreditation offers an external assessment, while ongoing bias mitigation addresses risks within the technology. A structured implementation plan brings these safeguards into daily operations, with patient safety guiding each step.
Build a Foundation for Pharmacy AI Governance
Before deployment, establish approval authority within your pharmacy’s AI governance program. A committee with expertise in pharmacy, technology and compliance can evaluate proposed uses against organizational policies. Create a clear approval process, with named owners for clinical validation, data protection and performance monitoring.
The American Society of Health-System Pharmacists supports the use of AI where safety and effectiveness have been demonstrated. To apply its guidance, ensure formal governance and ongoing surveillance underpin your deployment decisions. Each tool’s authorization should identify appropriate care settings, medications and patient populations. Scheduled reassessments and a defined error-reporting process provide a structure for continued evaluation.
Keep Humans in the Loop With Active Oversight
Within those approved boundaries, your staff need instructions for handling individual AI recommendations. For medication-related decisions, specify when a pharmacist must intervene and who has authority to override the system. The resulting workflow should show how a questionable output reaches someone qualified to resolve it.
You can help counter systemic bias with explicit human decision-making processes. Match your level of oversight to the potential consequences of an error. Training should prepare your team to recognize a tool’s limitations and explain the reasoning behind accepting or challenging a recommendation.
Validate Responsible AI in Pharmacy Through Accreditation
With governance and oversight established, you can seek an external assessment of responsible AI use in pharmacy settings. One option is URAC, a nationwide accrediting organization that recognizes more than 1,000 healthcare organizations across its programs.
Its Healthcare AI Accreditation evaluates organizational governance, defined AI use, monitoring and oversight, risk management and accountability across the AI life cycle. Accreditation affirms conformance with URAC’s governance and process standards, helping your organization demonstrate responsible AI oversight while maintaining ownership of legal, regulatory, safety and effectiveness considerations.
Because its accreditation standards define expectations without prescribing implementation methods, you can choose how to meet them in your operations. Align preparation with your organization’s goals and the program’s scope. An assigned client relations manager and accreditor provide individualized support throughout the process.
Mitigate Bias to Protect Pharmacy AI Patient Safety
To protect patient safety in pharmacy AI, examine how models perform across different populations. For AI-enabled medical devices, transparency and bias warrant attention throughout the product life cycle. Ask vendors for subgroup performance results and for their plans to detect changes after deployment.
Models trained on limited or unrepresentative data can perpetuate bias. Your evaluation should examine data quality and whether relevant patient groups are adequately represented. Accepting flawed recommendations or rejecting appropriate ones may also raise liability concerns. Include both scenarios in training so your team practices applying clinical standards rather than automatically trusting or dismissing AI.
Prescribe Responsible AI Adoption
Your next implementation decision should reflect the strength of the safeguards already in place. Choose one proposed AI use and assess its approval criteria, intervention rules, accreditation readiness and population-specific risks. A documented gap assessment with an accountable owner and corrective actions provides a practical basis for deciding whether to proceed.
















